Delaware Crossing Investor Group

Vytala is a food technology company specializing in enhancing nutrition through innovative solutions. It operates a clinical nutrition business, offering structured lipid technology that improves nutrient absorption, particularly for those with fat malabsorption issues. This technology helps clients avoid nutrient deficiencies, gastrointestinal diseases, and chronic malnutrition, supporting overall health and well-being.

Measure Studio operates a content intelligence engine that helps digital publishers, brands, agencies, and influencers develop data-driven social media content strategies. The company's platform allows users to consolidate and analyze their social media data in a secure environment, facilitating informed decision-making for content creation. By providing a turnkey solution for managing analytics across multiple platforms, Measure Studio empowers its clients to enhance their content strategies and improve engagement with their audiences.

SunRay Scientific LLC is an advanced materials manufacturer based in Long Branch, New Jersey, specializing in the production of conductive adhesives and related products for flexible electronics. Founded in 1998, the company designs and manufactures anisotropic conductive adhesives, conductive inks, epoxies, and encapsulants that facilitate high-throughput processes in flexible circuitry and semiconductor packaging. SunRay Scientific serves various industries, including healthcare, military defense, automotive, and consumer electronics, providing solutions that enhance the performance and reliability of flexible, wearable electronics. The company's innovative offerings are aimed at revolutionizing the flexible hybrid and miniaturized electronics market, while generating revenue through material sales, licensing, and engineering services.

Vesteck is a clinical stage medical device company dedicated to developing innovative solutions for the treatment of aortic aneurysms and related conditions. The company specializes in proprietary technology aimed at the aortic repair, structural heart, and gastrointestinal markets. Its flagship product, the Suture-Tight™ nitinol suture delivery catheter, introduces a novel approach to endovascular aortic repair. This technology addresses critical challenges faced by physicians and patients by securely suturing endovascular grafts to the aorta during initial implants or repairs. Additionally, Vesteck's advancements aim to minimize issues such as graft migration and leaks, which can lead to complex and costly interventions. Through its focus on enhancing patient care and improving outcomes, Vesteck is positioned to make a significant impact in the medical device industry.

Ophidion is a biotechnology company focused on developing therapeutics for central nervous system disorders, particularly neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington's disease. Utilizing a Trojan horse strategy, the company exploits an endogenous receptor-mediated transport system to deliver small molecule drugs and biologics directly into the brain. Ophidion specializes in gene-silencing therapies, including oligonucleotides and small interfering ribonucleic acids (siRNAs), which can be administered intravenously. In addition to its core focus on neurodegenerative diseases, Ophidion is advancing an innovative program aimed at treating anxiety-related disorders, which includes a patented companion biomarker diagnostic to optimize patient selection for treatment. The company's platform technology is versatile, capable of delivering various classes of drugs, including macromolecules like gene therapeutics, antibodies, and peptides, positioning Ophidion at the forefront of therapeutic advancements in CNS treatment.

ThruPore Technologies Inc., established in 2012 and based in Bear, Delaware, specializes in the development and production of porous carbon support structures for industrial catalysts. The company manufactures heterogeneous catalysts in both pellet and powder forms, with a focus on palladium on carbon reactions. ThruPore's products cater to clients in the precious metal catalysts, carbon-only catalysts, fuel cell, and battery materials industries, offering superior catalysts that enhance dispersion and improve end product refinement.

Tobly is a developer of a cloud-based online rental platform specializing in construction equipment rental services. The company provides a range of major equipment, including cranes, scissor lifts, and excavators. Tobly's platform allows clients to efficiently manage the entire lifecycle of the rental process, streamlining operations for construction projects.

OnlySky is a cloud-based software platform that offers a customizable, white-label solution for ski areas, allowing guests to create their ideal skiing experience directly on the resort's website. The platform integrates various functionalities, enabling ski area staff to manage inventory, eCommerce, point of sale systems, ski school operations, and events from a single interface. By eliminating upfront fees and ensuring user-friendliness, OnlySky has become a preferred choice for independent ski areas across North America and snow schools globally. The technology enhances guest engagement, facilitating processes such as equipment rental and instructor booking through users' smartphones, ultimately improving the overall guest experience at ski resorts.

Life.io is the world’s first web-based platform specifically designed to help people make better decisions every moment, to take care of themselves more, to engage more, to simply live more. Delivered through insurance companies or employers, it’s always on, sharing inspired ideas on how to live better today and every day after.

Annovis Bio, Inc., established in 2008 and headquartered in Berwyn, Pennsylvania, is a clinical-stage drug development company specializing in therapies for neurodegenerative disorders. Its primary focus is on Alzheimer's disease (AD) and Parkinson's disease (PD). Annovis Bio has two main compounds in clinical trials: ANVS401, currently in Phase 2a trials for early-stage AD and PD, as well as other chronic neurodegenerative conditions; and ANVS301, in Phase I trials to enhance cognitive function in advanced stages of AD. Additionally, the company is developing ANVS405 to protect the brain following traumatic brain injury or stroke.

Hulafrog operates a network of local websites and digital community guides, connecting parents with kid-focused events, businesses, and each other. Founded in 2010 and based in Atlantic Highlands, New Jersey, the company enables local businesses to promote their services and activities, while allowing parents to discover nearby resources such as classes, camps, restaurants, and festivals via web, mobile devices, and email. Hulafrog generates revenue through advertising packages sold at local, regional, and national levels.

Novira Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Doylestown, Pennsylvania, focused on the discovery and development of antiviral drugs targeting chronic hepatitis B (HBV) and human immunodeficiency virus (HIV) infections. Founded in 2006, the company specializes in creating first-in-class oral therapeutics that inhibit the viral capsid, offering innovative treatment options both as standalone therapies and in combination with existing treatments. Novira's antiviral drugs aim to address significant limitations associated with current therapies for chronic HBV and HIV, particularly the challenges of drug resistance and the need for lifelong treatment. By employing a novel mechanism of action, Novira Therapeutics seeks to provide more effective and potentially curative solutions for these global health issues. As of December 2015, Novira operates as a subsidiary of Johnson & Johnson.

Novira Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Doylestown, Pennsylvania, focused on the discovery and development of antiviral drugs targeting chronic hepatitis B (HBV) and human immunodeficiency virus (HIV) infections. Founded in 2006, the company specializes in creating first-in-class oral therapeutics that inhibit the viral capsid, offering innovative treatment options both as standalone therapies and in combination with existing treatments. Novira's antiviral drugs aim to address significant limitations associated with current therapies for chronic HBV and HIV, particularly the challenges of drug resistance and the need for lifelong treatment. By employing a novel mechanism of action, Novira Therapeutics seeks to provide more effective and potentially curative solutions for these global health issues. As of December 2015, Novira operates as a subsidiary of Johnson & Johnson.

Compliance Assurance Corporation specializes in on-demand governance, risk, and compliance solutions tailored for the insurance industry. Founded in 2003 and based in Pittsburgh, Pennsylvania, the company offers a range of products designed to streamline compliance processes and reduce associated costs. Among its key offerings is the Compliance Assured Enterprise, which provides comprehensive compliance packages for insurance carriers and their extended enterprises. Additionally, the Compliance Assured Producer Network equips Compliance Officers with essential tools to manage and mitigate risks linked to extended enterprise compliance. Through its innovative solutions, Compliance Assurance Corporation aims to enhance visibility and efficiency in governance, risk management, and compliance for its clients in the insurance sector.

NanoPack, Inc. is a materials science company founded in 2004 and located in Wayne, Pennsylvania. The company specializes in the development and marketing of barrier materials primarily for the food packaging industry. NanoPack's product offerings include polyethylene terephthalate, polylactic acid, and oriented polypropylene barrier coated films, along with liquid coatings used to create packaging films. These innovative materials are designed to enhance the preservation of various food products, including snack foods, dried fruits, coffee, cereals, and baked goods, while also being cost-effective and environmentally friendly.